Sign in
4

Changes in Ownership

Yarrow Bioscience, Inc. Filed Acc 0001209191-23-057220

President and CEO acquired 2,284 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Domzalski David · President and CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-11-30 Grant or award : show line 1 in the form +2,284 $2.81 $6,426 46,168 D
Loading xslF345X05/doc4.xml…